Bayesian Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bayesian Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,269	Closed	-$1.06M	–	1091
2023 Q2	$1.06M	Buy	+25,269	New	+$1.02M	0.11%	243
2020 Q4	–	Sell	-5,493	Closed	-$292K	–	704
2020 Q3	$292K	Buy	+5,493	New	+$327K	0.07%	350
2019 Q1	–	Sell	-7,300	Closed	-$287K	–	802
2018 Q4	$287K	Buy	7,300 +600	+9%	+$27.9K	0.06%	423
2018 Q3	$345K	Sell	6,700 -9,900	-60%	-$485K	0.06%	422
2018 Q2	$779K	Sell	16,600 -5,682	-26%	-$235K	0.18%	157
2018 Q1	$791K	Buy	+22,282	New	+$873K	0.2%	165
2017 Q3	–	Sell	-12,391	Closed	-$725K	–	687
2017 Q2	$725K	Buy	+12,391	New	+$644K	0.27%	128
2017 Q1	–	Sell	-12,400	Closed	-$652K	–	744
2016 Q4	$652K	Buy	+12,400	New	+$600K	0.16%	242

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bayesian Capital Management's SYNH Position: Q3 2023 in Review

Bayesian Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 25,269 shares — an estimated $1.06M sold.

Bayesian Capital Management first reported a position in SYNH in Q4 2016 and held it in 8 quarters. The position peaked at $1.06M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Bayesian Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Bayesian Capital Management sold 25,269 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.06M.
Bayesian Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 8 quarters.
Bayesian Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $1.06M in Q2 2023.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Bayesian Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.